{"id":53051,"date":"2023-01-18T18:02:48","date_gmt":"2023-01-18T17:02:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/"},"modified":"2023-01-18T18:02:48","modified_gmt":"2023-01-18T17:02:48","slug":"carafem-offers-new-immediate-evaluation-for-abortion-pills","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/","title":{"rendered":"carafem Offers NEW Immediate Evaluation for Abortion Pills"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–carafem, the most trusted provider of telehealth abortion care, is proud to make available Immediate Evaluation for Abortion Pills<\/b>. Clients living in Illinois, Colorado, New Mexico, and Maryland can immediately know if they are eligible to receive discretely packaged abortion pills by mail and can receive them without unnecessary delay and without a mandatory telephone call or video visit.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAbortion should be available for all who want it when they need it, and carafem\u2019s Immediate Evaluation for abortion pills is one way to make that a bit easier,\u201d says Melissa Grant, Chief Operations Officer, and Co-Founder of carafem<\/a>. \u201cOur medical professionals strive to make abortion services more convenient, personalized and private without compromising high-quality care.\u201d\n<\/p>\n

\nThe abortion pill consists of a combination of medications (often mifepristone and misoprostol) taken in sequence, and primarily used in the U.S. before 12 weeks of pregnancy. At carafem, costs average about $199, with additional financial assistance<\/a> available to those who qualify.\n<\/p>\n

\nImmediate Evaluation for abortion pills is a simple online process supported by carafem clinicians who are licensed, experienced providers of abortion care. The carafem medical team assures each client is medically qualified to receive this care and that all people are uniquely prepared and supported throughout the abortion process with pills.\n<\/p>\n

\nHere\u2019s how it works:<\/b>\n<\/p>\n

    \n
  1. \nAfter completing an Immediate Evaluation form located on the carafem website<\/a>, clients will be instantly aware of their eligibility to receive medically-supported abortion pills at home. As part of this process, carafem medical staff reviews all pertinent medical history and shares complete information and options around abortion with pills.\n<\/li>\n
  2. \nA licensed medical professional will approve each prescription and forward it to have medications sent directly to each client. The pills will be delivered in a discrete, unmarked package and come with a complete instruction guide and a uniquely designed comfort kit of items chosen to help make using the medications easier. The package is usually delivered within about 1-4 business days, depending upon the shipping option chosen, and the time of day order is placed.\n<\/li>\n
  3. \nAs part of this service, clients will receive secure text updates from Cara, carafem\u2019s online virtual assistant. Cara will track shipments, provide private, accurate information about using the medications from the carafem medical team, and confidentially answer questions while providing support to carafem clients any time, day or night.\u201c\n<\/li>\n<\/ol>\n

    \ncarafem<\/a> has provided high-quality, compassionate abortions to thousands of people in over 18 states across the United States, both in-person and through online visits,\u201d adds Grant. \u201cWith the launch of Immediate Evaluation for Abortion Pills, carafem is continuing to transform the client experience of abortion care and increase availability for those who need it.\u201d\n<\/p>\n

    \nAbout carafem:<\/b>\n<\/p>\n

    \ncarafem<\/a><\/i> provides convenient, modern, and professional abortion care as well as customized birth control options so people can control the number and spacing of their children. carafem is changing the environment of abortion care by making its services and information accessible, understandable, and supportive. carafem currently has health centers in the Washington DC, Atlanta, GA, Chicago, IL, and Nashville, TN metro areas and a telehealth abortion care program providing at-home care in Colorado, Connecticut, Washington, DC, Delaware, Iowa, Illinois, Massachusetts, Maryland, Maine, Minnesota, New Jersey, New Mexico, Nevada, Rhode Island, Virginia, and Vermont.<\/i>\n<\/p>\n

    Contacts<\/b> <\/p>\n

    \nwww.carafem.org<\/a><\/i>
    1-855-SAY-CARA<\/i>\n<\/p>\n

    \nVenessa Santos
    \n
    venessa@gcomworks.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    WASHINGTON–(BUSINESS WIRE)–carafem, the most trusted provider of telehealth abortion care, is proud to make available Immediate Evaluation for Abortion Pills. Clients living in Illinois, Colorado, New Mexico, and Maryland can immediately know if they are eligible to receive discretely packaged abortion pills by mail and can receive them without unnecessary delay and without a mandatory … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53051","6":"format-standard","7":"category-industry"},"yoast_head":"\ncarafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"carafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–carafem, the most trusted provider of telehealth abortion care, is proud to make available Immediate Evaluation for Abortion Pills. Clients living in Illinois, Colorado, New Mexico, and Maryland can immediately know if they are eligible to receive discretely packaged abortion pills by mail and can receive them without unnecessary delay and without a mandatory ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T17:02:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"carafem Offers NEW Immediate Evaluation for Abortion Pills\",\"datePublished\":\"2023-01-18T17:02:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/\"},\"wordCount\":558,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005774\\\/en\\\/522644\\\/21\\\/carafem.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/\",\"name\":\"carafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005774\\\/en\\\/522644\\\/21\\\/carafem.jpg\",\"datePublished\":\"2023-01-18T17:02:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005774\\\/en\\\/522644\\\/21\\\/carafem.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005774\\\/en\\\/522644\\\/21\\\/carafem.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/carafem-offers-new-immediate-evaluation-for-abortion-pills\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"carafem Offers NEW Immediate Evaluation for Abortion Pills\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"carafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/","og_locale":"en_US","og_type":"article","og_title":"carafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–carafem, the most trusted provider of telehealth abortion care, is proud to make available Immediate Evaluation for Abortion Pills. Clients living in Illinois, Colorado, New Mexico, and Maryland can immediately know if they are eligible to receive discretely packaged abortion pills by mail and can receive them without unnecessary delay and without a mandatory ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T17:02:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"carafem Offers NEW Immediate Evaluation for Abortion Pills","datePublished":"2023-01-18T17:02:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/"},"wordCount":558,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/","url":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/","name":"carafem Offers NEW Immediate Evaluation for Abortion Pills - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg","datePublished":"2023-01-18T17:02:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005774\/en\/522644\/21\/carafem.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/carafem-offers-new-immediate-evaluation-for-abortion-pills\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"carafem Offers NEW Immediate Evaluation for Abortion Pills"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53051"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53051\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}